MAPK8 and Alzheimer disease: In addition, SHX pill confers a therapeutic potential to AD-like pathology of Aβ42 overexpressing Drosophila model via suppression of the hyperactivation of JNK activity and apoptosis, as well as a potential as a therapeutic drug for the treatment of AD and Parkinson’s disease [16–18].